Transoma starts enrollment in atrial fibrillation study
Do you know when to trade TSMA ?
TSMA | Quote | Chart | News | PowerRating -- Transoma Medical, a developer of implantable, wireless diagnostic and monitoring devices, has reported the first patient enrollment and implant in a long-term study to monitor patients who have been prescribed catheter ablation therapy for atrial fibrillation at risk of recurrence of AF after the procedure.
The Imagine clinical study is designed for long-term evaluation of atrial fibrillation (AF) recurrence after ablation using the Sleuth AT system. The timing and true degree of recurrence in post-ablation paroxysmal AF patients has not been studied until now due to technology limitations.
Conventional cardiac monitors that rely on symptomatic activation of electrocardiogram (ECG) storage carry the risk of missing asymptomatic events. Additionally, current external monitoring systems are limited by duration of monitoring and other factors including skin irritation from regular application of electrodes and general patient compliance, Transoma said.
Sleuth AT is reportedly the only cardiac monitoring system that allows physicians to program the capture of high-quality ECG strips at frequent intervals, providing a new level of insight into complex arrhythmias that are often asymptomatic and frequently changing.
Brian Brockway, founder and CEO of Transoma Medical, said: "Physicians are looking for a continuous monitoring system that provides improved detection and monitoring capabilities over existing options while minimizing patient compliance issues. We believe Sleuth AT is a unique and superior method for monitoring AF and efficacy of current and future therapies."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon
For full details on (TSMA) TSMA. (TSMA) has Short Term PowerRatings at TradingMarkets. Details on (TSMA) Short Term PowerRatings is available at This Link.
- Transoma Medical Begins Clinical Study to Track Recurrence of Atrial Fibrillation - 09/25/09
- Transoma Medical Enrolls First Patient in Clinical Study Comparing Use of External Recorders with Implantable Monitors to Track - 09/22/09
- Transoma Medical Begins First Patient Enrollment in Clinical Study - 07/31/09
- Transoma Medical Announces First Patient Enrollment in Clinical Study to Evaluate Recurrence of Atrial Fibrillation Post Cathete - 07/28/09
- Transoma Medical Gets FDA Marketing Clearance for Sleuth AT Data Review Feature - 06/08/09
- More News >>
